METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Clinical trials for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer-Fighting virus plus chemo and immunotherapy takes on lung cancer in new trial
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease got worse after initial treatment. It combines an injected virus (Olvi-Vec) that targets cancer cells, followed by chemotherapy and an immunotherapy drug, and compares it to standard chemotherapy a…
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New combo aims to keep advanced lung cancer in check
Disease control Recruiting nowThis study tests whether combining two drugs (cabozantinib and pembrolizumab) as ongoing treatment can help keep advanced squamous lung cancer from growing. It is for people whose cancer was controlled after initial chemotherapy plus immunotherapy. About 36 adults will participat…
Matched conditions: METASTATIC SQUAMOUS NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC